Sculptor Capital’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Sculptor Capital’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-241,700	Closed	-$16.8K	–	471
2023 Q3	$16.8K	Hold	241,700	–	–	﹤0.01%	329
2023 Q2	$33.7K	Hold	241,700	–	–	﹤0.01%	301
2023 Q1	$20.5K	Sell	241,700 -8,300	-3%	-$668	﹤0.01%	411
2022 Q4	$11.5K	Hold	250,000	–	–	﹤0.01%	659
2022 Q3	$36K	Hold	250,000	–	–	﹤0.01%	816
2022 Q2	$27K	Hold	250,000	–	–	﹤0.01%	980
2022 Q1	$57K	Buy	+250,000	New	+$64.9K	﹤0.01%	1058

Sculptor Capital's BIOSW Position: Q4 2023 in Review

Sculptor Capital sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 241,700 shares — an estimated $16.8K sold.

Sculptor Capital first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $57K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Sculptor Capital reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Sculptor Capital sold 241,700 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $16.8K.
Sculptor Capital first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Sculptor Capital's BioPlus Acquisition Corp. Warrants position peaked at $57K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Sculptor Capital's 13F filing for Q4 2023, filed 14 Feb 2024.